Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
Fiscal Year 2023 Omnibus Summary
This detailed summary of the FY 2023 Omnibus focuses on those provisions of most interest to children’s hospitals.
COVID-19 Emergency Declaration Timeline
This chart contains updated information on the various COVID-19 emergency declarations, including timelines, processes for renewal and current expiration dates.
The Facts About COVID-19 and Children
Read the latest data on kids' COVID-19 cases, hospitalizations and vaccination numbers.